Literature DB >> 21289598

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts.

Brad C Astor1, Kunihiro Matsushita, Ron T Gansevoort, Marije van der Velde, Mark Woodward, Andrew S Levey, Paul E de Jong, Josef Coresh, Brad C Astor1, Kunihiro Matsushita, Ron T Gansevoort, Marije van der Velde, Mark Woodward, Andrew S Levey, Paul E de Jong, Josef Coresh, Meguid El-Nahas, Kai-Uwe Eckardt, Bertram L Kasiske, Jackson Wright, Larry Appel, Tom Greene, Adeera Levin, Ognjenka Djurdjev, David C Wheeler, Martin J Landray, John N Townend, Jonathan Emberson, Laura E Clark, Alison Macleod, Angharad Marks, Tariq Ali, Nicholas Fluck, Gordon Prescott, David H Smith, Jessica R Weinstein, Eric S Johnson, Micah L Thorp, Jack F Wetzels, P J Blankestijn, A D van Zuilen, Vandana Menon, Mark Sarnak, Gerald Beck, Florian Kronenberg, Barbara Kollerits, Marc Froissart, Benedicte Stengel, Marie Metzger, Giuseppe Remuzzi, Piero Ruggenenti, Annalisa Perna, H J Lambers Heerspink, Barry Brenner, Dick de Zeeuw, Peter Rossing, Hans-Henrik Parving, Priscilla Auguste, Kasper Veldhuis, Yaping Wang, Laura Camarata, Beverly Thomas, Tom Manley.   

Abstract

We studied here the independent associations of estimated glomerular filtration rate (eGFR) and albuminuria with mortality and end-stage renal disease (ESRD) in individuals with chronic kidney disease (CKD). We performed a collaborative meta-analysis of 13 studies totaling 21,688 patients selected for CKD of diverse etiology. After adjustment for potential confounders and albuminuria, we found that a 15 ml/min per 1.73 m² lower eGFR below a threshold of 45 ml/min per 1.73 m² was significantly associated with mortality and ESRD (pooled hazard ratios (HRs) of 1.47 and 6.24, respectively). There was significant heterogeneity between studies for both HR estimates. After adjustment for risk factors and eGFR, an eightfold higher albumin- or protein-to-creatinine ratio was significantly associated with mortality (pooled HR 1.40) without evidence of significant heterogeneity and with ESRD (pooled HR 3.04), with significant heterogeneity between HR estimates. Lower eGFR and more severe albuminuria independently predict mortality and ESRD among individuals selected for CKD, with the associations stronger for ESRD than for mortality. Thus, these relationships are consistent with CKD stage classifications based on eGFR and suggest that albuminuria provides additional prognostic information among individuals with CKD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21289598      PMCID: PMC3917543          DOI: 10.1038/ki.2010.550

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  19 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts.

Authors:  Ron T Gansevoort; Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh
Journal:  Kidney Int       Date:  2011-02-02       Impact factor: 10.612

3.  Definition and classification of CKD: the debate should be about patient prognosis--a position statement from KDOQI and KDIGO.

Authors:  Kai-Uwe Eckardt; Jeffrey S Berns; Michael V Rocco; Bertram L Kasiske
Journal:  Am J Kidney Dis       Date:  2009-05-05       Impact factor: 8.860

4.  Timing of onset of CKD-related metabolic complications.

Authors:  Olivier Moranne; Marc Froissart; Jerome Rossert; Cedric Gauci; Jean-Jacques Boffa; Jean Philippe Haymann; Mona Ben M'rad; Christian Jacquot; Pascal Houillier; Benedicte Stengel; Bruno Fouqueray
Journal:  J Am Soc Nephrol       Date:  2008-11-12       Impact factor: 10.121

5.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

Authors:  Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh; Ron T Gansevoort
Journal:  Lancet       Date:  2010-05-17       Impact factor: 79.321

6.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Authors:  Jackson T Wright; George Bakris; Tom Greene; Larry Y Agodoa; Lawrence J Appel; Jeanne Charleston; DeAnna Cheek; Janice G Douglas-Baltimore; Jennifer Gassman; Richard Glassock; Lee Hebert; Kenneth Jamerson; Julia Lewis; Robert A Phillips; Robert D Toto; John P Middleton; Stephen G Rostand
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

7.  Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment.

Authors:  M J Landray; J Thambyrajah; F J McGlynn; H J Jones; C Baigent; M J Kendall; J N Townend; D C Wheeler
Journal:  Am J Kidney Dis       Date:  2001-09       Impact factor: 8.860

8.  Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts.

Authors:  Marije van der Velde; Kunihiro Matsushita; Josef Coresh; Brad C Astor; Mark Woodward; Andrew Levey; Paul de Jong; Ron T Gansevoort; Marije van der Velde; Kunihiro Matsushita; Josef Coresh; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Ron T Gansevoort; Andrew Levey; Meguid El-Nahas; Kai-Uwe Eckardt; Bertram L Kasiske; Toshiharu Ninomiya; John Chalmers; Stephen Macmahon; Marcello Tonelli; Brenda Hemmelgarn; Frank Sacks; Gary Curhan; Allan J Collins; Suying Li; Shu-Cheng Chen; K P Hawaii Cohort; Brian J Lee; Areef Ishani; James Neaton; Ken Svendsen; Johannes F E Mann; Salim Yusuf; Koon K Teo; Peggy Gao; Robert G Nelson; William C Knowler; Henk J Bilo; Hanneke Joosten; Nanno Kleefstra; K H Groenier; Priscilla Auguste; Kasper Veldhuis; Yaping Wang; Laura Camarata; Beverly Thomas; Tom Manley
Journal:  Kidney Int       Date:  2011-02-09       Impact factor: 10.612

9.  Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD Study.

Authors:  Benjamin Dieplinger; Thomas Mueller; Barbara Kollerits; Joachim Struck; Eberhard Ritz; Arnold von Eckardstein; Meinhard Haltmayer; Florian Kronenberg
Journal:  Kidney Int       Date:  2008-12-03       Impact factor: 10.612

10.  Long-term outcomes in nondiabetic chronic kidney disease.

Authors:  V Menon; X Wang; M J Sarnak; L H Hunsicker; M Madero; G J Beck; A J Collins; J W Kusek; A S Levey; T Greene
Journal:  Kidney Int       Date:  2008-03-12       Impact factor: 10.612

View more
  270 in total

Review 1.  Nondialysis chronic kidney disease in 2011: Progression, prediction, populations and possibilities.

Authors:  Adeera Levin
Journal:  Nat Rev Nephrol       Date:  2011-12-06       Impact factor: 28.314

2.  Estimated GFR, albuminuria, and complications of chronic kidney disease.

Authors:  Lesley A Inker; Josef Coresh; Andrew S Levey; Marcello Tonelli; Paul Muntner
Journal:  J Am Soc Nephrol       Date:  2011-09-30       Impact factor: 10.121

3.  Impact of non-invasive cardiovascular screening programs as a predictor of cardiovascular events among asymptomatic chronic kidney disease patients.

Authors:  Akihiro Sawai; Yoshinari Yasuda; Susumu Suzuki; Hideki Ishii; Motomitsu Goto; Sawako Kato; Mutsuharu Hayashi; Shoichi Maruyama; Toyoaki Murohara; Yutaka Oiso; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2015-09-24       Impact factor: 2.801

4.  Past Decline Versus Current eGFR and Subsequent Mortality Risk.

Authors:  David M J Naimark; Morgan E Grams; Kunihiro Matsushita; Corri Black; Iefke Drion; Caroline S Fox; Lesley A Inker; Areef Ishani; Sun Ha Jee; Akihiko Kitamura; Janice P Lea; Joseph Nally; Carmen Alicia Peralta; Dietrich Rothenbacher; Seungho Ryu; Marcello Tonelli; Hiroshi Yatsuya; Josef Coresh; Ron T Gansevoort; David G Warnock; Mark Woodward; Paul E de Jong
Journal:  J Am Soc Nephrol       Date:  2015-12-11       Impact factor: 10.121

5.  Similar Outcomes for Two Anemia Treatment Strategies among Elderly Hemodialysis Patients with Diabetes.

Authors:  M Thamer; Y Zhang; J Kaufman; D Cotter; M A Hernán
Journal:  J Endocrinol Diabetes       Date:  2014

6.  Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial.

Authors:  Daniel E Weiner; Meyeon Park; Hocine Tighiouart; Alin A Joseph; Myra A Carpenter; Nitender Goyal; Andrew A House; Chi-Yuan Hsu; Joachim H Ix; Paul F Jacques; Clifton E Kew; S Joseph Kim; John W Kusek; Todd E Pesavento; Marc A Pfeffer; Stephen R Smith; Matthew R Weir; Andrew S Levey; Andrew G Bostom
Journal:  Am J Kidney Dis       Date:  2018-07-20       Impact factor: 8.860

7.  Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study.

Authors:  Giuseppe Penno; Anna Solini; Emanuela Orsi; Enzo Bonora; Cecilia Fondelli; Roberto Trevisan; Monica Vedovato; Franco Cavalot; Olga Lamacchia; Marco Scardapane; Antonio Nicolucci; Giuseppe Pugliese
Journal:  Diabetologia       Date:  2018-07-21       Impact factor: 10.122

8.  Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial.

Authors:  Benjamin M Scirica; Ofri Mosenzon; Deepak L Bhatt; Jacob A Udell; Ph Gabriel Steg; Darren K McGuire; KyungAh Im; Estella Kanevsky; Christina Stahre; Mikaela Sjöstrand; Itamar Raz; Eugene Braunwald
Journal:  JAMA Cardiol       Date:  2018-02-01       Impact factor: 14.676

9.  Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKD.

Authors:  Dominik Steubl; Markus P Schneider; Heike Meiselbach; Jennifer Nadal; Matthias C Schmid; Turgay Saritas; Vera Krane; Claudia Sommerer; Seema Baid-Agrawal; Jakob Voelkl; Fruzsina Kotsis; Anna Köttgen; Kai-Uwe Eckardt; Jürgen E Scherberich
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-14       Impact factor: 8.237

10.  Comparison of associations of urine protein-creatinine ratio versus albumin-creatinine ratio with complications of CKD: a cross-sectional analysis.

Authors:  Herrick Fisher; Chi-Yuan Hsu; Eric Vittinghoff; Feng Lin; Nisha Bansal
Journal:  Am J Kidney Dis       Date:  2013-09-14       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.